Bosh sahifaPTX • ASX
add
Prescient Therapeutics Ltd
Yopilish kursi
0,047 $
Kunlik diapazon
0,045 $ - 0,047 $
Yillik diapazon
0,037 $ - 0,063 $
Bozor kapitalizatsiyasi
34,82 mln AUD
Oʻrtacha hajm
865,20 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
ASX
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (AUD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 624,21 ming | -35,64% |
Joriy xarajat | 1,93 mln | -34,84% |
Sof foyda | -1,22 mln | 32,33% |
Sof foyda marjasi | -196,17 | -5,13% |
Har bir ulushga tushum | — | — |
EBITDA | -1,31 mln | 34,45% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (AUD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 8,41 mln | -54,41% |
Jami aktivlari | 16,58 mln | -33,04% |
Jami passivlari | 934,79 ming | -56,56% |
Umumiy kapital | 15,65 mln | — |
Tarqatilgan aksiyalar | 805,32 mln | — |
Narxi/balansdagi bahosi | 2,35 | — |
Aktivlardan daromad | -19,69% | — |
Kapitaldan daromad | -20,82% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (AUD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,22 mln | 32,33% |
Operatsiyalardan naqd pul | -2,89 mln | -66,14% |
Sarmoyadan naqd pul | 1,00 mln | -50,00% |
Moliyadan naqd pul | -148,11 ming | -1 732,02% |
Naqd pulning sof oʻzgarishi | -2,05 mln | -885,92% |
Boʻsh pul | -805,50 ming | 31,59% |
Haqida
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Tashkil etilgan
22-may, 1986
Xodimlar soni
3
